Literature DB >> 18616039

Morphine: axon regeneration, neuroprotection, neurotoxicity, tolerance, and neuropathic pain.

Idanis Berrios1, Cristina Castro, Damien P Kuffler.   

Abstract

Opioids have been used medicinally for millennia for their potent effects on nociception. However, the past 20 years have led to important insights into the influences and mechanisms of opioid actions, which are more extensive than merely analgesia, including human synthesis of opioids, critical roles of opioids during development and following nerve injury, and actions of different opiate alkaloids and their receptors. Due to the vast literature on opioids, the scope of this review has been limited to opioid actions in maintaining neuron viability during development, promoting neurological function following nerve injuries, in inflammation, disease and against ischemia; alleviating neuropathic pain; raising and lowering cellular immunity; and mechanisms modifying morphine tolerance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18616039

Source DB:  PubMed          Journal:  P R Health Sci J        ISSN: 0738-0658            Impact factor:   0.705


  4 in total

1.  Early systemic granulocyte-colony stimulating factor treatment attenuates neuropathic pain after peripheral nerve injury.

Authors:  Po-Kuan Chao; Kwok-Tung Lu; Yun-Lin Lee; Jin-Chung Chen; Hung-Li Wang; Yi-Ling Yang; Mei-Yun Cheng; Ming-Feng Liao; Long-Sun Ro
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

Review 2.  Avicenna's Canon of Medicine: a review of analgesics and anti-inflammatory substances.

Authors:  Shahla Mahdizadeh; Maryam Khaleghi Ghadiri; Ali Gorji
Journal:  Avicenna J Phytomed       Date:  2015 May-Jun

3.  Delay of morphine tolerance by palmitoylethanolamide.

Authors:  Lorenzo Di Cesare Mannelli; Francesca Corti; Laura Micheli; Matteo Zanardelli; Carla Ghelardini
Journal:  Biomed Res Int       Date:  2015-03-22       Impact factor: 3.411

4.  Angiotensin II receptor type 1 blocker candesartan improves morphine tolerance by reducing morphine‑induced inflammatory response and cellular activation of BV2 cells via the PPARγ/AMPK signaling pathway.

Authors:  Wenxin Zhao; Feiyan Shen; Jixiang Yao; Shanshan Su; Zhongmin Zhao
Journal:  Mol Med Rep       Date:  2022-08-25       Impact factor: 3.423

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.